Volumetric and Linear Imaging Response After Stereotactic Radiotherapy for Vestibular Schwannoma

SRT achieved durable control of VS across SRS, HFSRT, and FSRT in this single-institution cohort, with few salvage interventions. The three-axis volumetric criterion (20% increase) outperformed the MLD 2 mm threshold and correlated strongly with contoured gross tumor volume (GTV). Early progression subsided by 24 months, and stability at 12 and 24 months predicted five-year control. Between-regimen divergence at 24 months was consistent with SRS-driven pseudoprogression, with five-year progression remaining similar across regimens. Baseline imaging offered limited prognostic value, whereas clinical worsening, mainly hearing decline, correlated with volumetric progression. Annual MRI after year 1 is generally adequate, with tighter intervals reserved for selected patients. Prospective, audiometry-standardized studies are warranted for validating hearing-related endpoints.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-12-01
DOI
https://doi.org/10.7759/cureus.98252
Primary Topic
Meningioma and schwannoma management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Volumetric and Linear Imaging Response After Stereotactic Radiotherapy for Vestibular Schwannoma

PCT Costa, Sofia Conde, Mavilde Arantes, Eduardo Melani Rocha et al.
Cureus
Meningioma and schwannoma management
article

Volumetric and Linear Imaging Response After Stereotactic Radiotherapy for Vestibular Schwannoma

PCT Costa, Sofia Conde, Mavilde Arantes, Eduardo Melani Rocha, Artur Aguiar, Andreia Pires
article en

Abstract

SRT achieved durable control of VS across SRS, HFSRT, and FSRT in this single-institution cohort, with few salvage interventions. The three-axis volumetric criterion (20% increase) outperformed the MLD 2 mm threshold and correlated strongly with contoured gross tumor volume (GTV). Early progression subsided by 24 months, and stability at 12 and 24 months predicted five-year control. Between-regimen divergence at 24 months was consistent with SRS-driven pseudoprogression, with five-year progression remaining similar across regimens. Baseline imaging offered limited prognostic value, whereas clinical worsening, mainly hearing decline, correlated with volumetric progression. Annual MRI after year 1 is generally adequate, with tighter intervals reserved for selected patients. Prospective, audiometry-standardized studies are warranted for validating hearing-related endpoints.

CureusVol. 17(12)
IPO Porto (PT)
Openalex Percentile: Top 51%
Meningioma and schwannoma management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.